期刊文献+

抗高血压药物的研究进展和临床应用 被引量:20

抗高血压药物的研究进展和临床应用
在线阅读 下载PDF
导出
摘要 高血压疾病已成为危害当今人类生命健康的头号杀手之一,我国近年来的发病率呈明显上升趋势,所以抗高血压药物的研究与临床运用也在不断的探索与实践中发展,抗高血压药更新换代速度较快,在原有药物的基础上,越来越多的抗高血压药物被应用于临床。该文综述了抗高血压药的研究进展,以期对抗高血压药的临床应用及科研工作提供指导。 Hypertension disease has become the harm now one of human life and health top-quality murderers, our country recent years disease incidence rate assumed the obvious trend of escalation, therefore the anti-hypertension medicine research and the clinical utilization also developed in the unceasing exploration and the practice, the anti-hypertension medicine renewal speed was quick, in the original medicine foundation, the more and more many anti-hypertension medicine is gpplied clinically. This article summarized the anti-hyperten- sion medicine research progress, provides the instruction by the time resistance hypertension medicine clinical practice and the scientific research work .
作者 吴金珊 李佳
出处 《中国实用医药》 2009年第23期231-232,共2页 China Practical Medicine
关键词 高血压 抗高血压药物 临床运用 Hypertension Anti-hypertension medicine Clinical utilization
  • 相关文献

参考文献11

二级参考文献71

  • 1王钦贤.非洛地平和硝苯吡淀治疗高血压病比较分析[J].河北医学,1989,4(5):67-67.
  • 2[1]Chin HL,Buchan DA. Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor. [J].Ann Intern Med,1990,112:312
  • 3[2]Sander GE,Mckinnte JJ,Greenberg SS,et al. Angiotensinconverting enzyme inhibitors and angiotensin Ⅱ receptor angagonists in the treatment of heart failure caused by left ventricular systolic dysfunction. [J]. Prog Cardiovasc Dis,1999,41:265
  • 4[3]Johnston CI, Risvanis J. Preclinical pharmacology of angiotensin Ⅱ receptor antagonists: Update and outstanding issues. [J]. Am J Hypertens, 1997,10: 306S
  • 5[4]Mealy N. Elisartan potassium. [J]. Drugs Fut, 1996,21:139
  • 6[5]Ries UJ,Mihm G,Narr B,et al. 6-Substituted benzimidazoles as new nonpeptide biological activity and structureactivity relationship. [J]. J Med Chem, 1993,36: 4040
  • 7[6]Ellingboe JW,Collini MD,Chen J,et al. Metabolites of the angiotensin Ⅱ antagonist tasosartan: The importance of a second acidic group. [J]. J Med Chem, 1998,41: 4251
  • 8[7]Duncia JV,Chiu AT,Carini DJ,et al. The discovery of potent nonpeptide angiotensin Ⅱ receptor blockers: A new class of antihypertensives. [J]. J Med Chem, 1990,33:1312
  • 9[8]Griffiths GJ,Hauck MB,Kohr J,et al. Novel syntheses of 2-butyl-5-chloro-3H-imidazole-4-carbaldehyde: A key intermediate for the synthesis of the angiotensin Ⅱ antagonist losartan. [J]. J Org Chem,1999,64:8084
  • 10[9]Bühlmayer P,Furet P. Valsartan, a potent, orally activeangiotensin Ⅱ antagonist developed from the structurally new amino acid series. [J]. Biorg Med Chem Letters,1994, 4:29

共引文献99

同被引文献177

引证文献20

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部